Works in American Journal of Hematology, 2021, Vol 96, Issue 8

Results: 33
    1
    2
    3
    4
    5
    6
    7

    TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. E306, doi. 10.1002/ajh.26235
    By:
    • Morabito, Fortunato;
    • Del Poeta, Giovanni;
    • Mauro, Francesca Romana;
    • Reda, Gianluigi;
    • Sportoletti, Paolo;
    • Laurenti, Luca;
    • Coscia, Marta;
    • Herishanu, Yair;
    • Bossio, Sabrina;
    • Varettoni, Marzia;
    • Murru, Roberta;
    • Chiarenza, Annalisa;
    • Visentin, Andrea;
    • Condoluci, Adalgisa;
    • Moia, Riccardo;
    • Pietrasanta, Daniela;
    • Loseto, Giacomo;
    • Consoli, Ugo;
    • Scortechini, Ilaria;
    • Recchia, Anna Grazia
    Publication type:
    Article
    8

    Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 989, doi. 10.1002/ajh.26234
    By:
    • Ramírez, María José;
    • Pujol, Roser;
    • Trujillo‐Quintero, Juan Pablo;
    • Minguillón, Jordi;
    • Bogliolo, Massimo;
    • Río, Paula;
    • Navarro, Susana;
    • Casado, José A.;
    • Badell, Isabel;
    • Carrasco, Estela;
    • Balmaña, Judith;
    • Català, Albert;
    • Sevilla, Julián;
    • Beléndez, Cristina;
    • Argilés, Bienvenida;
    • López, Mónica;
    • Díaz de Heredia, Cristina;
    • Rao, Gayatri;
    • Nicoletti, Eileen;
    • Schwartz, Jonathan D.
    Publication type:
    Article
    9
    10

    Hemolytic crisis due to Covid‐19 vaccination in a woman with cold agglutinin disease.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. E288, doi. 10.1002/ajh.26214
    By:
    • Pérez‐Lamas, Lucía;
    • Moreno‐Jiménez, Gemma;
    • Tenorio‐Núñez, María C.;
    • Velázquez‐Kennedy, Kyra;
    • Jiménez‐Chillón, Carlos;
    • Astibia‐Mahillo, Beatriz;
    • Núñez‐Torrón, Claudia;
    • García‐Gutiérrez, Valentín;
    • Jiménez‐Martín, Ana;
    • Vallés‐Carboneras, Ana;
    • López‐Jiménez, Javier F.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16

    Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 979, doi. 10.1002/ajh.26230
    By:
    • Boddicker, Nicholas J.;
    • Larson, Melissa C.;
    • Castellino, Alessia;
    • Herrmann, Joerg;
    • Inwards, David J.;
    • Thanarajasingam, Gita;
    • Maurer, Matthew J.;
    • Allmer, Cristine;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.;
    • Habermann, Thomas M.;
    • Villarraga, Hector R.;
    • Slager, Susan L.;
    • Cerhan, James R.;
    • Thompson, Carrie A.
    Publication type:
    Article
    17
    18
    19

    Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 945, doi. 10.1002/ajh.26210
    By:
    • Abeykoon, Jithma P.;
    • Zanwar, Saurabh;
    • Ansell, Stephen M.;
    • Muchtar, Eli;
    • He, Rong;
    • Greipp, Patricia T.;
    • King, Rebecca L.;
    • Ailawadhi, Sikander;
    • Paludo, Jonas;
    • Larsen, Jeremy T.;
    • Habermann, Thomas M.;
    • Inwards, David;
    • Go, Ronald S.;
    • Thanarajasingam, Gita;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Thompson, Carrie A.;
    • Witzig, Thomas E.;
    • Lacy, Martha;
    • Gonsalves, Wilson
    Publication type:
    Article
    20

    Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with non‐Hodgkin lymphoma treated with B‐cell depleting immunotherapy.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 934, doi. 10.1002/ajh.26209
    By:
    • Duléry, Rémy;
    • Lamure, Sylvain;
    • Delord, Marc;
    • Di Blasi, Roberta;
    • Chauchet, Adrien;
    • Hueso, Thomas;
    • Rossi, Cédric;
    • Drenou, Bernard;
    • Deau Fischer, Bénédicte;
    • Soussain, Carole;
    • Feugier, Pierre;
    • Noël, Nicolas;
    • Choquet, Sylvain;
    • Bologna, Serge;
    • Joly, Bertrand;
    • Philippe, Laure;
    • Kohn, Milena;
    • Malak, Sandra;
    • Fouquet, Guillemette;
    • Daguindau, Etienne
    Publication type:
    Article
    21
    22
    23

    Long‐term results of low‐intensity chemotherapy with clofarabine or cladribine combined with low‐dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 914, doi. 10.1002/ajh.26206
    By:
    • Kadia, Tapan M.;
    • Ravandi, Farhad;
    • Borthakur, Gautam;
    • Konopleva, Marina;
    • DiNardo, Courtney D.;
    • Daver, Naval;
    • Pemmaraju, Naveen;
    • Kanagal‐Shamanna, Rashmi;
    • Wang, Xuemei;
    • Huang, Xuelin;
    • Pierce, Sherry;
    • Rausch, Caitlin;
    • Burger, Jan;
    • Ferrajoli, Alessandra;
    • Jain, Nitin;
    • Popat, Uday;
    • Estrov, Zeev;
    • Verstovsek, Srdan;
    • Jabbour, Elias;
    • Garcia‐Manero, Guillermo
    Publication type:
    Article
    24
    25
    26
    27

    Myeloid and lymphoid vacuolation in VEXAS syndrome.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 1056, doi. 10.1002/ajh.26098
    By:
    • Fan, Bingwen E.;
    • Cao, Ling;
    • Gallardo, Christian A.;
    • Lee, Shang M. S.;
    • Koh, Li W.;
    • Goh, Liuh L.;
    • Ong, Kiat H.;
    • Kuperan, Ponnudurai
    Publication type:
    Article
    28

    Effectiveness of ibrutinib as first‐line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab‐bendamustine: Results of study on 486 cases outside clinical trials.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. E269, doi. 10.1002/ajh.26201
    By:
    • Morabito, Fortunato;
    • Tripepi, Giovanni;
    • Del Poeta, Giovanni;
    • Mauro, Francesca Romana;
    • Reda, Gianluigi;
    • Sportoletti, Paolo;
    • Laurenti, Luca;
    • Coscia, Marta;
    • Herishanu, Yair;
    • Bossio, Sabrina;
    • Varettoni, Marzia;
    • Murru, Roberta;
    • Chiarenza, Annalisa;
    • Visentin, Andrea;
    • Condoluci, Adalgisa;
    • Moia, Riccardo;
    • Pietrasanta, Daniela;
    • Loseto, Giacomo;
    • Consoli, Ugo;
    • Scortechini, Ilaria
    Publication type:
    Article
    29
    30
    31
    32

    FLT3 inhibitor based induction and allogeneic stem cell transplant in complete remission 1 improve outcomes in patients with newly diagnosed Acute Myeloid Leukemia with very low FLT3 allelic burden.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. E275, doi. 10.1002/ajh.26202
    By:
    • Yilmaz, Musa;
    • Daver, Naval;
    • Borthakur, Gautam;
    • Kadia, Tapan;
    • DiNardo, Courtney;
    • Kanagal‐Shamanna, Rashmi;
    • Loghavi, Sanam;
    • Oran, Betul;
    • Popat, Uday R.;
    • Pierce, Sherry;
    • Jabbour, Elias;
    • Short, Nicholas J.;
    • Issa, Ghayas;
    • Ohanian, Maro;
    • Konopleva, Marina;
    • Patel, Keyur;
    • Kantarjian, Hagop;
    • Ravandi, Farhad
    Publication type:
    Article
    33

    Issue Information.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 8, p. 893, doi. 10.1002/ajh.25891
    Publication type:
    Article